Some analysts have also said that orforglipron will be easier to manufacture at scale, which is crucial as demand for obesity and diabetes injections outpaces supply
Since microdosing has not been proven to support weight loss, it cannot be relied on for maintaining your new weight once youve reached it
According to the manufacturer, Novo Nordisk, Wegovy can cause unpleasant gastrointestinal side effects, like nausea, vomiting, diarrhea, and stomach pain, and may result in hypoglycemia (low blood sugar) when combined with other medications that lower blood sugar, like insulin
Regarding dermatologic outcomes, the frequency of HS flares reported by patients decreased notably from approximately one flare every 8.5 weeks to one every 12 weeks
[PubMed] [Google Scholar] 4.Flegal KM, Carroll MD, Ogden CL, Curtin LR